Lingyan Jin

1.9k total citations · 1 hit paper
23 papers, 1.4k citations indexed

About

Lingyan Jin is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cell Biology. According to data from OpenAlex, Lingyan Jin has authored 23 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 4 papers in Cell Biology. Recurrent topics in Lingyan Jin's work include Atrial Fibrillation Management and Outcomes (5 papers), Protein Degradation and Inhibitors (5 papers) and Ubiquitin and proteasome pathways (5 papers). Lingyan Jin is often cited by papers focused on Atrial Fibrillation Management and Outcomes (5 papers), Protein Degradation and Inhibitors (5 papers) and Ubiquitin and proteasome pathways (5 papers). Lingyan Jin collaborates with scholars based in China, United States and South Korea. Lingyan Jin's co-authors include Michael Rapé, Adam J. Williamson, Isabelle Philipp, Katherine E. Wickliffe, Weiru Wang, Guowei Fang, Randy Schekman, Amita Gorur, Kanika Bajaj Pahuja and Steven Magnuson and has published in prestigious journals such as Nature, Cell and Chemical Reviews.

In The Last Decade

Lingyan Jin

21 papers receiving 1.4k citations

Hit Papers

Ubiquitin-dependent regulation of COPII coat size and fun... 2012 2026 2016 2021 2012 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingyan Jin China 10 1.1k 326 277 138 134 23 1.4k
Vyacheslav Akimov Denmark 17 1.2k 1.1× 247 0.8× 303 1.1× 211 1.5× 170 1.3× 34 1.6k
Willem‐Jan Keune United Kingdom 17 704 0.6× 314 1.0× 209 0.8× 172 1.2× 104 0.8× 20 1.1k
Troels Zakarias Kristiansen United States 12 1.1k 1.0× 271 0.8× 466 1.7× 112 0.8× 206 1.5× 15 1.7k
Matthew P. Stokes United States 20 1.2k 1.0× 188 0.6× 395 1.4× 93 0.7× 197 1.5× 49 1.6k
Wenge Zhu United States 21 1.4k 1.3× 274 0.8× 440 1.6× 98 0.7× 349 2.6× 44 1.7k
Daniel Y.L. Mao Canada 17 1.2k 1.0× 203 0.6× 374 1.4× 67 0.5× 154 1.1× 21 1.4k
Suyong Choi United States 22 835 0.7× 512 1.6× 216 0.8× 154 1.1× 111 0.8× 29 1.3k
Damian Fermin United States 13 889 0.8× 207 0.6× 142 0.5× 114 0.8× 155 1.2× 28 1.3k
Hidemi Hayashi Japan 14 801 0.7× 222 0.7× 424 1.5× 185 1.3× 107 0.8× 29 1.2k

Countries citing papers authored by Lingyan Jin

Since Specialization
Citations

This map shows the geographic impact of Lingyan Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingyan Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingyan Jin more than expected).

Fields of papers citing papers by Lingyan Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingyan Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingyan Jin. The network helps show where Lingyan Jin may publish in the future.

Co-authorship network of co-authors of Lingyan Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Lingyan Jin. A scholar is included among the top collaborators of Lingyan Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingyan Jin. Lingyan Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jin, Lingyan, Lulu Gong, Yizhen Wang, et al.. (2025). Swim Exercise Mitigates BCAA ‐Induced Atrial Remodeling and AF Susceptibility via Inhibition of Bax‐Mediated Mitochondrial Apoptosis. The FASEB Journal. 39(22). e71227–e71227.
2.
Jin, Lingyan, et al.. (2025). Succinate predisposes mice to atrial fibrillation by impairing mitochondrial function via SUCNR1/AMPK axis. Redox Biology. 81. 103576–103576. 4 indexed citations
3.
Qin, Xinghua, Lingyan Jin, Yixin Wang, et al.. (2025). Long-term glucosamine supplementation aggravates atrial fibrillation susceptibility by impairing AMPK signaling. Life Sciences. 362. 123380–123380. 3 indexed citations
4.
Jin, Lingyan, Young‐Hoon Kim, Jeong Mo Bae, et al.. (2025). Clinicopathological and molecular features of genome-stable colorectal cancers.. PubMed. 40(3). 381–388.
5.
Qin, Xinghua, Peng Liu, Lingyan Jin, et al.. (2024). Exerkine β-aminoisobutyric acid protects against atrial structural remodeling and atrial fibrillation in obesity via activating AMPK signaling and improving insulin sensitivity. Biomedicine & Pharmacotherapy. 171. 116137–116137. 10 indexed citations
6.
Qin, Xinghua, et al.. (2024). Electro-metabolic coupling in atrial fibrillation: A deeper understanding of the metabolic driver. Biomedicine & Pharmacotherapy. 180. 117536–117536. 5 indexed citations
7.
Park, Hye Eun, Lingyan Jin, Nam‐Yun Cho, et al.. (2024). Concomitant expression patterns of CDX2 and SATB2 as prognostic factors in stage III colorectal cancers. Annals of Diagnostic Pathology. 71. 152289–152289. 2 indexed citations
8.
Kim, Young-Hoon, et al.. (2023). Prognostic significance of STING expression in solid tumor: a systematic review and meta-analysis. Frontiers in Oncology. 13. 1244962–1244962. 8 indexed citations
11.
Fu, Yuping, Peng Liu, Lingyan Jin, et al.. (2022). Left bundle branch area pacing: A promising modality for cardiac resynchronization therapy. Frontiers in Cardiovascular Medicine. 9. 901046–901046. 7 indexed citations
12.
Jin, Lingyan, et al.. (2021). Hyper-O-GlcNAcylation impairs insulin response against reperfusion-induced myocardial injury and arrhythmias in obesity. Biochemical and Biophysical Research Communications. 558. 126–133. 13 indexed citations
13.
Nagata, Denise E. de Almeida, Eugene Y. Chiang, Suchit Jhunjhunwala, et al.. (2019). Regulation of Tumor-Associated Myeloid Cell Activity by CBP/EP300 Bromodomain Modulation of H3K27 Acetylation. Cell Reports. 27(1). 269–281.e4. 54 indexed citations
14.
Raisner, Ryan, Samir Kharbanda, Lingyan Jin, et al.. (2018). Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. Cell Reports. 24(7). 1722–1729. 223 indexed citations
15.
Jin, Lingyan, Emily Chan, Ehud Segal, et al.. (2017). Therapeutic Targeting of the CBP/p300 Bromodomain Blocks the Growth of Castration-Resistant Prostate Cancer. Cancer Research. 77(20). 5564–5575. 105 indexed citations
16.
17.
Jin, Lingyan, Kanika Bajaj Pahuja, Katherine E. Wickliffe, et al.. (2012). Ubiquitin-dependent regulation of COPII coat size and function. Nature. 482(7386). 495–500. 257 indexed citations breakdown →
18.
Williamson, Adam J., Lingyan Jin, & Michael Rapé. (2009). Preparation of Synchronized Human Cell Extracts to Study Ubiquitination and Degradation. Methods in molecular biology. 545. 301–312. 15 indexed citations
19.
Wickliffe, Katherine E., Adam J. Williamson, Lingyan Jin, & Michael Rapé. (2009). The Multiple Layers of Ubiquitin-Dependent Cell Cycle Control. Chemical Reviews. 109(4). 1537–1548. 69 indexed citations
20.
Jin, Lingyan, et al.. (2008). Mechanism of Ubiquitin-Chain Formation by the Human Anaphase-Promoting Complex. Cell. 133(4). 653–665. 434 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026